The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbm Regulatory News (IBM)

Share Price Information for Ibm (IBM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 118.95
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 118.95
High: 0.00
Low: 0.00
Prev. Close: 118.95
IBM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

31 Oct 2013 16:20

RNS Number : 9203R
Societe Generale SA
31 October 2013
 



Date: 31/10/2013

Not for the distribution, directly or indirectly in to the United States or any jurisdiction in which such distribution would be unlawful.

International Business Machines Corp

Stabilisation Notice

Societe Generale (contact: Ronan Murphy; telephone: 020 7676 7463) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The Securities:

Issuer:

International Business Machines Corp

Guarantor (if any):

NA

Aggregate Nominal Amount:

EUR 1 Bn

Description:

12 Year 2.75%

Offer price:

99.93%

Stabilisation:

Stabilising managers:

DB (B&D)/ GSI / SG CIB / UNICREDIT

Stabilisation Period expected to start on:

31/10/2013

Stabilisation period expected to end no later than:

29/10/2013

Existance, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordancewith SG's Policy.

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilization action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAEAKEFDFXDFFF
Date   Source Headline
26th Apr 20247:00 amPRNDoc re: Form 8-K
25th Apr 20247:00 amPRN1st Quarter Results
25th Apr 20247:00 amPRNDoc re Form 8-K
8th Apr 20247:00 amPRNDoc re: Form DEF A14A
19th Mar 20247:00 amPRNDoc re: Form 8-K
12th Mar 20241:04 pmPRNDoc re (Form DEFA14A)
12th Mar 20241:02 pmPRNDoc re (Form Def 14A)
12th Mar 202412:52 pmPRNIBM Annual Report
27th Feb 20247:00 amPRNDoc re: Form 8-K
27th Feb 20247:00 amPRNDoc re: Form 10-K
5th Feb 20247:00 amPRNDoc re: Form 8-K
2nd Feb 20247:00 amPRNDoc re: Form 8-K
26th Jan 20247:00 amPRNDoc re: Form 8-K
25th Jan 20247:00 amPRNForm 8-K
25th Jan 20247:00 amPRNFinal Results
13th Dec 20237:00 amPRNDoc re Form 8K
31st Oct 20236:12 pmPRNDoc re Form 10-Q
27th Oct 20237:00 amPRNDoc re Form 8-K
26th Oct 20237:00 amPRN3rd Quarter Results
26th Oct 20237:00 amPRNDoc re: Form 8-K
1st Aug 20237:00 amPRNDoc re: Form 8-K
26th Jul 20237:00 amPRNDoc re: Form 10-Q
21st Jul 20237:00 amPRNDoc re Form 8-K
20th Jul 20237:00 amPRNDoc re Form 8K
20th Jul 20237:00 amPRNIBM Releases Second-Quarter Results
11th Apr 20227:00 amPRNDoc re: Form DEFA 14A
1st Apr 20227:00 amPRNDoc re: Form 8-K
8th Mar 202212:22 pmPRNAnnual Financial Report
8th Mar 20227:00 amPRNDoc re Form DEF 14A
8th Mar 20227:00 amPRNDoc re Form DEFA 14A
23rd Feb 20227:00 amPRNDoc re Form 10-K
9th Feb 20227:00 amPRNDoc re Form 8-K
7th Feb 20227:00 amPRNDoc re: Form 8-K
1st Feb 20223:36 pmPRNDividend Declaration
26th Jan 20227:00 amPRNDoc re: Form 8-K
25th Jan 20227:00 amPRNDoc re: Form 8-K
25th Jan 20227:00 amPRNFinal Results
29th Dec 20217:00 amPRNDoc re: Form 8-K
30th Nov 20217:00 amPRNDoc re: Form 8-K
8th Nov 20217:00 amPRNDoc re: 10-Q
5th Nov 20217:00 amPRNDoc re: Form 8-K
4th Nov 20217:00 amBUSIBM Completes the Separation of Kyndryl
29th Oct 20214:40 pmRNSSecond Price Monitoring Extn
29th Oct 20214:35 pmRNSPrice Monitoring Extension
26th Oct 20213:39 pmBUSIBM Board Approves Regular Quarterly Cash Dividend
25th Oct 20217:00 amPRNDoc re: Form 8-K
22nd Oct 20217:00 amPRNDoc Re: Form 8-K
21st Oct 20217:00 amPRNDoc re: Form 8-K
21st Oct 20217:00 amBUSIBM Reports 2021 Third-Quarter Results
18th Oct 20217:00 amPRNDoc re: 8-K

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.